ACTAVIS LABS FL INC FDA Approval ANDA 078035

ANDA 078035

ACTAVIS LABS FL INC

FDA Drug Application

Application #078035

Documents

Review2013-10-23

Application Sponsors

ANDA 078035ACTAVIS LABS FL INC

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL0.5MG0CABERGOLINECABERGOLINE

FDA Submissions

ORIG1AP2008-04-21
LABELING; LabelingSUPPL5AP2013-01-31STANDARD
LABELING; LabelingSUPPL10AP2019-12-13STANDARD
LABELING; LabelingSUPPL11AP2021-04-16STANDARD

Submissions Property Types

SUPPL5Null15
SUPPL10Null7
SUPPL11Null15

CDER Filings

ACTAVIS LABS FL INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 78035
            [companyName] => ACTAVIS LABS FL INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"CABERGOLINE","activeIngredients":"CABERGOLINE","strength":"0.5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"CABERGOLINE","submission":"CABERGOLINE","actionType":"0.5MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.